Allspring SMID Cap Growth Fund reports on Q4 market rotations and performance drivers like Teva and Natera. Read the full ...

Allspring SMID Cap Growth Fund reviews Q4 2025 performance and identifies high-quality growth opportunities. Read the full ...

Revenue growth of 13% in 2025 was driven by a record surge in demand, though tablet volume lagged behind new prescriptions ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...

Teva Pharmaceutical Industries (NYSE:TEVA) has recently drawn investor attention after a sustained share price move, with the stock returning 7.6% over the past month and 38.2% in the past 3 months.

On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate ...

SIPTU has said it is engaging with management at Teva Pharmaceuticals over threatened redundancies at its plant in Waterford.

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, ...

Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing ...

Israel-based generics giant Teva Industries and France’s Medincell announced that the US Food and Drug Administration has accepted the New Drug Application for olanzapine extended-release injectable ...

If anti-Israel agitators wish to avoid being described as terrorists, they might begin by ceasing to terrorise ordinary people.